Related Experiment Video
Updated: Jul 3, 2025

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
Transforming growth factor-β receptors: versatile mechanisms of ligand activation
Zheng-Jie Chia1,2,3, Ying-Nan Cao4, Peter J Little1,4
1School of Pharmacy, The University of Queensland, Brisbane, QLD, 4102, Australia.
Abstract:
Transforming growth factor-β (TGF-β) signaling is initiated by activation of transmembrane TGF-β receptors (TGFBR), which deploys Smad2/3 transcription factors to control cellular responses. Failure or dysregulation in the TGF-β signaling pathways leads to pathological conditions. TGF-β signaling is regulated at different levels along the pathways and begins with the liberation of TGF-β ligand from its latent form. The mechanisms of TGFBR activation display selectivity to cell types, agonists, and TGF-β isoforms, enabling precise control of TGF-β signals. In addition, the cell surface compartments used to release active TGF-β are surprisingly vibrant, using thrombospondins, integrins, matrix metalloproteinases and reactive oxygen species. The scope of TGFBR activation is further unfolded with the discovery of TGFBR activation initiated by other signaling pathways. The unique combination of mechanisms works in series to trigger TGFBR activation, which can be explored as therapeutic targets. This comprehensive review provides valuable insights into the diverse mechanisms underpinning TGFBR activation, shedding light on potential avenues for therapeutic exploration.
Insights
Transforming growth factor-β (TGF-β) receptor activation initiates signaling pathways. Understanding these diverse activation mechanisms offers potential therapeutic targets for pathological conditions.
Area of Science:
- Molecular Biology
- Cell Signaling
- Biochemistry
Background:
- Transforming growth factor-β (TGF-β) signaling is crucial for cellular functions.
- Dysregulation of TGF-β pathways is linked to various pathological conditions.
- TGF-β signaling begins with the activation of transmembrane TGF-β receptors (TGFBR).
Purpose of the Study:
- To provide a comprehensive review of the diverse mechanisms of TGFBR activation.
- To highlight the cell-type and agonist selectivity in TGFBR activation.
- To explore potential therapeutic targets for modulating TGF-β signaling.
Main Methods:
- Review of existing literature on TGF-β signaling and TGFBR activation.
- Analysis of molecular mechanisms involved in TGF-β ligand liberation and receptor activation.
- Examination of cell surface components and cross-talk with other signaling pathways.
Main Results:
- TGFBR activation involves intricate mechanisms, including ligand liberation from latent forms.
- Cell surface compartments utilize thrombospondins, integrins, MMPs, and ROS for active TGF-β release.
- TGFBR activation can be initiated by other signaling pathways, indicating complex cross-talk.
- Mechanisms exhibit selectivity based on cell type, agonists, and TGF-β isoforms.
Conclusions:
- TGFBR activation is a highly regulated process with diverse contributing mechanisms.
- Understanding these mechanisms reveals potential therapeutic strategies for diseases associated with TGF-β pathway dysregulation.
- Further exploration of these pathways can lead to novel therapeutic interventions.
Related Concept Videos
TGF - β Signaling Pathway
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
Amplifying Signals via Enzymatic Cascade
Receptor Tyrosine Kinases
Signal Transduction: Overview
Typically, signal transduction involves three...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...

